The role of endoscopy in the evaluation and management of patients with solid pancreatic neoplasia, Gastrointest Endosc, vol.83, pp.17-28, 2016. ,
Nanofluidic digital PCR for KRAS mutation detection and quantification in gastrointestinal cancer, Clin Chem, vol.58, pp.1332-1341, 2012. ,
The clinical utility of serum CA 19-9 in the diagnosis, prognosis and management of pancreatic adenocarcinoma: An evidence based appraisal, J Gastrointest Oncol, vol.3, pp.105-119, 2012. ,
, Sci Transl Med, vol.6, pp.224-248, 2014.
Interference of heparin with the polymerase chain reaction, BioTechniques, vol.9, p.166, 1990. ,
Circulating tumor cells in locally advanced pancreatic adenocarcinoma: the ancillary CirCe 07 study to the LAP 07 trial, Ann Oncol, vol.24, pp.2057-2061, 2013. ,
Detection of KRAS mutations in circulating tumor DNA by Digital PCR in early stages of pancreatic cancer, Clin Chem, vol.62, pp.1482-1491, 2016. ,
Validation of biomarkers that complement CA19.9 in detecting early pancreatic cancer, Clin Cancer Res, vol.20, pp.5787-5795, 2014. ,
EUS-guided FNA of pancreatic metastases: a multicenter experience, Gastrointest Endosc, vol.61, pp.689-696, 2005. ,
Liquid biopsies: genotyping circulating tumor DNA, J Clin Oncol, vol.32, pp.579-586, 2014. ,
Circulating tumor cells (Ctc) and kras mutant circulating free Dna (cfdna) detection in peripheral blood as biomarkers in patients diagnosed with exocrine pancreatic cancer, BMC Cancer, vol.15, p.797, 2015. ,
Endoscopic ultrasound-guided fine needle aspiration biopsy of patients with suspected pancreatic cancer: diagnostic accuracy and acute and 30-day complications, Am J Gastroenterol, vol.98, pp.2663-2668, 2003. ,
Yield of endoscopic ultrasound-guided fine-needle aspiration biopsy in patients with suspected pancreatic carcinoma, Cancer, vol.99, pp.285-292, 2003. ,
COSMIC: somatic cancer genetics at high-resolution, Nucleic Acids Res, vol.45, pp.777-783, 2017. ,
Circulating tumor cells: the evolving concept and the inadequacy of their enrichment by EpCAM-based methodology for basic and clinical cancer research, Ann Oncol, vol.25, pp.1506-1516, 2014. ,
Prognostic value of circulating tumor DNA in patients undergoing curative resection for pancreatic cancer, Br J Cancer, vol.115, pp.59-65, 2016. ,
Endosonography-guided fine needle aspiration biopsy in the evaluation of pancreatic masses, Am J Gastroenterol, vol.97, pp.1386-1391, 2002. ,
Morphological analysis of circulating tumor cells in patients undergoing surgery for non-small cell lung carcinoma using the isolation by size of epithelial tumor cell (ISET) method, Cytopathology, vol.23, pp.30-38, 2012. ,
Usefulness of circulating tumor cell detection in pancreatic adenocarcinoma diagnosis, Am J Gastroenterol, vol.108, pp.152-155, 2013. ,
Multiplex preamplification of serum DNA to facilitate reliable detection of extremely rare cancer mutations in circulating DNA by digital PCR, J Mol Diagn, vol.18, pp.235-243, 2016. ,
Pancreatic cancer, Lancet, vol.388, pp.73-85, 2016. ,
A pilot study to explore circulating tumor cells in pancreatic cancer as a novel biomarker, Br J Cancer, vol.106, pp.508-516, 2012. ,
Detection of K-ras gene mutation by liquid biopsy in patients with pancreatic cancer, Cancer, vol.121, pp.2271-2280, 2015. ,
Circulating tumor cells found in patients with localized and advanced pancreatic cancer, Pancreas, vol.44, pp.547-550, 2015. ,
Detection of circulating tumor cells in patients with pancreatic cancer: a preliminary result, J Hepatobiliary Pancreat Surg, vol.15, pp.189-195, 2008. ,
Metastatic colorectal cancer KRAS genotyping in routine practice: results and pitfalls, Mod Pathol, vol.24, pp.1090-1100, 2011. ,
Optimal number of EUS-guided fine needle passes needed to obtain a correct diagnosis, Gastrointest Endosc, vol.59, pp.475-481, 2004. ,
Diagnostic value of serum Ca 19-9 antigen in chronic pancreatitis and pancreatic adenocarcinoma, Gastroenterol Clin Biol, vol.22, pp.152-159, 1998. ,
Circulating tumor cell phenotype predicts recurrence and survival in pancreatic adenocarcinoma, Ann Surg, vol.264, pp.1073-1081, 2016. ,
Clinical implications of genomic alterations in the tumour and circulation of pancreatic cancer patients, Nat Commun, vol.6, p.7686, 2015. ,
,
Short report: Monitoring ESR1 mutations by circulating tumor DNA in aromatase inhibitor resistant metastatic breast cancer, Int J Cancer, vol.137, pp.2513-2519, 2015. ,
URL : https://hal.archives-ouvertes.fr/hal-02353282
Clinical value of chip-based digital-PCR platform for the detection of circulating DNA in metastatic colorectal cancer, Dig Liver Dis, vol.47, pp.884-890, 2015. ,
URL : https://hal.archives-ouvertes.fr/hal-02353257
High levels of cell-free circulating nucleic acids in pancreatic cancer are associated with vascular encasement, metastasis and poor survival, Cancer Invest, vol.33, pp.78-85, 2015. ,
Tissue polypeptide specific antigen (TPS), a marker for differentiation between pancreatic carcinoma and chronic pancreatitis. A comparative study with CA 19-9, Cancer, vol.89, pp.83-88, 2000. ,
The clinical utility of the CA 19-9 tumor-associated antigen, Am J Gastroenterol, vol.85, pp.350-355, 1990. ,
Carbohydrate antigen 19-9 for differential diagnosis of pancreatic carcinoma and chronic pancreatitis, World J Gastroenterol, vol.21, pp.4323-4333, 2015. ,
Value of pancreatic resection for cancer metastatic to the pancreas, J Surg Res, vol.156, pp.189-198, 2009. ,
Role of repeated endoscopic ultrasound-guided fine needle aspiration in small solid pancreatic masses with previous indeterminate and negative cytological findings, Dig Dis, vol.26, pp.377-382, 2008. ,
Clinical utility of circulating tumor DNA for molecular assessment in pancreatic, cancer. Sci Rep, vol.5, p.18425, 2015. ,
Diagnostic accuracy of endoscopic ultrasound-guided fine needle aspiration for suspected pancreatic malignancy in relation to the size of lesions, J Gastroenterol Hepatol, vol.26, pp.1256-1261, 2011. ,
Yield of EUS-guided FNA of pancreatic masses in the presence or the absence of chronic pancreatitis, Gastrointest Endosc, vol.62, pp.728-736, 2005. ,
Multiple KRAS mutations in pancreatic adenocarcinoma: molecular features of neoplastic clones indicate the selection of divergent populations of tumor cells, Int J Surg Pathol, vol.21, pp.546-552, 2013. ,
Sensitive detection of mono-and polyclonal ESR1 mutations in primary tumors, metastatic lesions and cell free DNA of breast cancer patients, Clin Cancer Res, vol.22, pp.1130-1137, 2015. ,
Diagnostic, prognostic, and predictive biomarkers in pancreatic cancer, J Surg Oncol, vol.107, pp.15-22, 2013. ,
Role of endoscopic ultrasound-guided fine needle aspiration (EUS-FNA) for diagnosis of solid pancreatic masses, Dig Endosc, vol.23, issue.1, pp.29-33, 2011. ,
Cell-Free DNA next-generation sequencing in pancreatobiliary carcinomas, Cancer Discov, vol.5, pp.1040-1048, 2015. ,